Fulgent Genetics (FLGT) Non Operating Interest Expenses (2023 - 2026)

Fulgent Genetics has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting $59000.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses rose 247.06% year-over-year to $59000.0; the TTM figure through Jun 2026 stood at $120000.0 (up 41.18% YoY), while the FY2025 annual figure was $75000.0, up 144.12% from the prior year.
• Non Operating Interest Expenses came in at $59000.0 for Q2 2026 at Fulgent Genetics, up from $17000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $70000.0 in Q3 2023 to a low of -$249000.0 in Q1 2024.
• Average Non Operating Interest Expenses over 4 years is -$7166.7, with a median of $17000.0 recorded in 2025.
• Year-over-year, Non Operating Interest Expenses plunged 80.0% in 2024 and soared 247.06% in 2026.
• Over 4 years, Non Operating Interest Expenses stood at -$137000.0 in 2023, then soared by 129.2% to $40000.0 in 2024, then plunged by 60.0% to $16000.0 in 2025, then jumped by 268.75% to $59000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $59000.0 in Q2 2026, $17000.0 in Q1 2026, and $16000.0 in Q4 2025.